BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23855126)

  • 1. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
    Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.
    Ye L; Li J; Zhang T; Wang X; Wang Y; Zhou Y; Liu J; Parekh HK; Ho W
    Virus Res; 2012 Sep; 168(1-2):33-40. PubMed ID: 22728816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.
    Henry SD; Metselaar HJ; Lonsdale RC; Kok A; Haagmans BL; Tilanus HW; van der Laan LJ
    Gastroenterology; 2006 Nov; 131(5):1452-62. PubMed ID: 17101321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
    Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
    Liu JP; Ye L; Wang X; Li JL; Ho WZ
    Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin.
    El-Farrash MA; Aly HH; Watashi K; Hijikata M; Egawa H; Shimotohno K
    Microbiol Immunol; 2007; 51(1):127-33. PubMed ID: 17237608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
    von Hahn T; Schiene-Fischer C; Van ND; Pfaender S; Karavul B; Steinmann E; Potthoff A; Strassburg C; Hamdi N; Abdelaziz AI; Sarrazin C; Müller T; Berg T; Trépo E; Wedemeyer H; Manns MP; Pietschmann T; Ciesek S
    Gastroenterology; 2012 Aug; 143(2):439-47.e1. PubMed ID: 22580540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
    Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
    Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
    Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
    Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.
    Hoppe-Seyler K; Sauer P; Lohrey C; Hoppe-Seyler F
    Hepatology; 2012 Jul; 56(1):9-16. PubMed ID: 22271223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
    Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.